Advanced search×

PULMONARY ALVEOLAR PROTEINOSIS. ENDOBRONCHIAL TREATMENT.

J RAMIREZ and G D CAMPBELL

Ann Intern Med (1965) PMID 14330592

Version: za2963e q8za5 q8zbd q8zc0 q8zd1 q8ze3 q8zf2 q8zg3

Similar articles you may find interesting…

  1. Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer.
    Yuan-Zi Ye, Zhi-Hong Zhang, and Yan-Bei Zhang

    Med Oncol 30(2):595 (2013) PMID 23645556

    We designed a prospective study with five years of follow-up to evaluate Notch3 expression in NSCLC tissues and adjacent non-cancerous normal lung tissues from 131 patients undergoing surgical treatment by immunohistochemistry and western blot analysis. Notch3 had high expression in 67 of 131 cases...
  2. A1E inhibits proliferation and induces apoptosis in NCI-H460 lung cancer cells via extrinsic and intrinsic pathways.
    Yesol Bak, Sunyoung Ham, and Do-Young Yoon

    Mol Biol Rep (2013) PMID 23649764

    We assessed the molecular mechanisms involved in the anticancer effects of A1E, the extract of Korean medicinal herbs. We examined the role of the cytotoxic and apoptotic pathways in the cancer chemopreventive activity in non-small-cell lung cancer (NSCLC) cell lines NCI-H460 and NCI-H1299. A1E inhi...
  3. Chain-Shattering Polymeric Therapeutics with On-Demand Drug-Release Capability.
    Yanfeng Zhang, Qian Yin, and Jianjun Cheng

    Angew Chem Int Ed Engl (2013) PMID 23650111

    Trigger happy: Trigger-responsive chain-shattering polymeric therapeutics (CSPTs) were prepared by condensation polymerization of a UV- or hydrogen peroxide-responsive domain and a drug as co-monomers. Drug release can be started and stopped by starting and stopping the trigger treat...